Literature DB >> 14693176

Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio.

Rossana Lombardi1, Veena Chantarangkul, Marco Cattaneo, Armando Tripodi.   

Abstract

The measurement of plasma warfarin is required to investigate non-compliance, resistance to anticoagulation, drug metabolism and pharmacokinetic. Methods so far described are based on extraction of warfarin from plasma followed by reversed-phase HPLC. Extraction is the crucial step and may be performed in liquid- or solid-phase. The latter requires the preparation of columns, which makes the procedure variable. We investigated the suitability of the ready-for-use commercial cartridges for sample preparation. The method displayed between-run CV of 11.8%. Recovery was 99%. The coefficients of correlation between warfarin concentration in 50 patients and weekly dosage or INR were 0.55 (p<0.0001) or 0.25 (p=0.079).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14693176     DOI: 10.1016/j.thromres.2003.09.006

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Estimation of plasma levels of warfarin and 7-hydroxy warfarin by high performance liquid chromatography in patients receiving warfarin therapy.

Authors:  Dhakchinamoorthi Krishna Kumar; Deepak Gopal Shewade; Subramani Parasuraman; Sundaram Rajan; Jayaraman Balachander; B V Sai Chandran; Chandrasekaran Adithan
Journal:  J Young Pharm       Date:  2013-03-16

2.  The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians.

Authors:  Ahmed M L Bedewy; Salah A Sheweita; Mostafa Hasan Mostafa; Lamia Saeed Kandil
Journal:  Indian J Hematol Blood Transfus       Date:  2016-09-27       Impact factor: 0.900

3.  Monitoring the distribution of warfarin in blood plasma.

Authors:  Annika M Rosengren; Björn C G Karlsson; Ian A Nicholls
Journal:  ACS Med Chem Lett       Date:  2012-06-20       Impact factor: 4.345

4.  VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.

Authors:  Qiang Gu; Yan Kong; Jörn Schneede; Ying-Bin Xiao; Lin Chen; Qian-Jin Zhong; Xue-Feng Wang; Jia Hao; Bai-Cheng Chen; Jing-Jin Chen
Journal:  Eur J Clin Pharmacol       Date:  2010-09-15       Impact factor: 2.953

5.  How to use warfarin assays in patient management: analysis of 437 warfarin measurements in a clinical setting.

Authors:  Kyunghoon Lee; Hye In Woo; Oh Young Bang; Young-Keun On; June Soo Kim; Soo-Youn Lee
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

6.  Separation and determination of warfarin enantiomers in human plasma using a novel polymeric surfactant for micellar electrokinetic chromatography-mass spectrometry.

Authors:  Jingguo Hou; Jie Zheng; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2007-04-21       Impact factor: 4.759

7.  Measurement of warfarin in the oral fluid of patients undergoing anticoagulant oral therapy.

Authors:  Silvia Ghimenti; Tommaso Lomonaco; Massimo Onor; Laura Murgia; Aldo Paolicchi; Roger Fuoco; Lucia Ruocco; Giovanni Pellegrini; Maria Giovanna Trivella; Fabio Di Francesco
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol.

Authors:  J-Pablo Salvador; Thomas Brettschneider; Christian Dorrer; M-Pilar Marco
Journal:  Front Bioeng Biotechnol       Date:  2022-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.